NEW YORK, April 13, 2018 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Foot Locker, Inc. (“Foot Locker”) (NYSE:FL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Foot Locker securities between August 19, 2016 and August 17, 2017, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/fl.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the class period, defendants made false and misleading statements and/or failed to disclose to investors that: (1) Foot Locker’s vendors were transitioning to selling through various online retailers, diminishing the utility of Foot Locker’s large number of brick and mortar stores and the once-high value of its exclusivity relationships with those vendors; (2) competition with online retailers had increased the pricing competition Foot Locker faced while also materially lowering the demand at Foot Locker stores; and (3) as a result of defendants’ failure to disclose this information, Foot Locker stock was artificially inflated to a high of $79.20 per share during the Class Period, while executives were able to sell over 192,000 shares of their personally held Foot Locker stock at artificially inflated prices for gross proceeds of $13.3 million.
On August 18, 2017, Foot Locker revealed poor second quarter 2017 financial results, and a 6% drop in quarterly same-store sales year-over-year, causing the substantial revenue miss. Foot Locker announced that it would close roughly 130 stores, more than the 100 stores it had previously announced it would close and on a conference call with investors and analysts that morning, Foot Locker said it expected weaker sales for the remainder of fiscal 2017. Following this news, Foot Locker stock dropped roughly 28% to close at $34.38 per share on August 18, 2017, on unusually high trading volume of more than 36.2 million shares traded.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/fl or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Foot Locker you have until May 8, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]


Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Capital One Says AML Review Led to Closure of Trump Organization Accounts
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Same sparkle, different story: how lab-grown diamonds are transforming the market 



